EMA:
* EMA: EMA STARTED A ROLLING REVIEW FOR VERSION OF COMIRNATY ADAPTED TO ORIGINAL SARS-COV-2 VIRUS AND TO ITS OMICRON SUBVARIANTS BA.4/5: 09/08/2022 Further company coverage:
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
{{#Source}}{{Source}}{{/Source}}{{#IsBlog}}
{{Disclaimer}}
{{/Disclaimer}}